Drospirenone and Ethinyl Estradiol Articles
Schering AG acquires 24.5% of Molypharma
1 June 2001
Schering AG's Yasmin registered in USA
21 May 2001
Schering AG to focus on special markets
20 April 2001
Schering AG to "grow faster than market"
16 March 2001
Healthy harvest of New Chemical Entities in 2000
2 January 2001
Stock Commentary Europe
28 September 2000
Stock Commentary Europe
14 September 2000
Europe approves Schering's Yasmin, US approvable letter for Imavist
7 September 2000
FDA requests more data for Schering's Yasmin
20 July 2000
FDA requests more data for Schering's Yasmin
20 July 2000
Schering's Yasmin approved in the Netherlands
13 April 2000
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
